INSIGHTS ON DRUG DEVELOPMENT

• Spray Dried Biologics For Injectable Dosage Forms

  Spray drying enables scalable production of stable, high‑concentration biologics as sterile powders, improving delivery, reducing costs, and overcoming limitations of traditional freeze‑drying methods.

• Spray Dried Biologics For Pulmonary Dosage Forms

  Spray drying creates stable inhalable biologic powders with controlled particle size, enabling effective lung delivery, improved stability, and scalable production for respiratory and systemic therapies.

• R&D Excellence at Asymchem's UK Facility

  Dave Henderson outlines R&D excellence at a UK facility, highlighting integrated labs, advanced experimentation, expert teams, and seamless progression from discovery through scale-up and manufacturing.

• Injection Site Reaction Screening Methodology

  Optimize drug formulations for solubility at physiological pH to reduce injection site reactions, enable high-concentration dosing, and enhance patient comfort and compliance.

• How CRISPR And LNP Accelerate Therapeutic Innovation Through Analytics

  9/2/2025

  CRISPR gene editing and lipid nanoparticle delivery are revolutionizing precision medicine. Discover how optimized LNP systems and advanced analytics accelerate therapeutic development.

• Amorphous Solids: Implications For Solubility And Stability

  5/6/2026

  Amorphous solids can enhance drug solubility and bioavailability but introduce stability risks, making careful characterization and control essential for successful pharmaceutical development and manufacturing.

• Native SEC-MALS Characterization Using A Chromatography Data System

  5/7/2026

  Native SEC‑MALS offers a calibration‑free way to accurately characterize peptide oligomers, helping scientists distinguish true higher‑order structures while avoiding bias.

• Understanding Adeno-Associated Virus Vector Impurities

  11/13/2025

  AAV vectors hold promise for gene therapy, but removing product-related impurities remains a challenge. Learn how cell line development and process optimization are advancing rAAV production.

• IP Considerations In Drug Development For Biotech Companies

  4/20/2026

  Integrate a strategic intellectual property approach early in drug development to streamline research, uncover opportunities, and maximize the return on your investment.